Prospective study of quality of life in patients with adrenocortical tumor

Prospective study of quality of life in patients with adrenocortical tumor - treatment of adrenocortical tumor and quality of life

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005282

Enrollment

100

Registered

2011-03-22

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenocortical tumor (including Cushing syndrome, Sub-clinical Cushing syndrome, Primary aldosteronism, non-functioning adrenal tumor)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have newly diagnosed Cushing syndrome, Sub-clinical Cushing syndrome, Primary aldosteronism, non-functioning adrenal tumor and who voluntary write informed consent.

Exclusion criteria

Exclusion criteria: Patients who don't accept participation. Patients who have the disease that influence endocrine tests, such as infectious, hepatic, and renal diseases. Patients who are inappropriate for this study by research director.

Design outcomes

Primary

Measure	Time frame
To evaluate changes in quality of life before and after treatment in patients with adrenocortical tumor	—

Secondary

Measure	Time frame
Comparison in quality of life between each diseases, treatments, complications. Relation between change in quality of life and endocrinological findings or clinical presentation.	—

Countries

Japan

Contacts

Public ContactNagai So

Hokkaido University Hospital Department of Medicine II

nagai-s@med.hokudai.ac.jp011-706-5916

Outcome results